| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |